Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
初步评价银杏总内酯滴丸不同给药剂量用于治疗急性缺血性脑卒中的有效性和安全性；探索银杏总内酯滴丸治疗急性缺血性脑卒中的量效关系，为后续临床试验设计提供依据。
CTR20190722Phase 2Completed
- Sponsor
- Hefei Innovation Pharmaceutical Technology
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ginkgo diterpene lactone meglumine in ischemic stroke, sponsored by Hefei Innovation Pharmaceutical Technology. Started Apr 2019; status: completed.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20190722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190722.